(-)-epigallocatechin 3-gallate increases expression ISO RGD:1606038 6480464 epigallocatechin gallate results in increased expression of DNMT3A mRNA CTD PMID:25839702 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of DNMT3A mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1620920 6480464 o, p'-DDT results in increased expression of DNMT3A mRNA CTD PMID:24096037 1,2-dimethylhydrazine increases expression ISO RGD:1620920 6480464 1, 2-Dimethylhydrazine results in increased expression of DNMT3A mRNA CTD PMID:22206623 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile affects expression EXP 6480464 Citalopram affects the expression of DNMT3A mRNA CTD PMID:21682946 1-naphthyl isothiocyanate increases expression ISO RGD:1620920 6480464 1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA CTD PMID:15913567 1-naphthyl isothiocyanate multiple interactions ISO RGD:1620920 6480464 O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1, 2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA] CTD PMID:15913567 17alpha-ethynylestradiol multiple interactions ISO RGD:1620920 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT3A mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1620920 6480464 Ethinyl Estradiol results in decreased expression of DNMT3A mRNA CTD PMID:31463084 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of DNMT3A mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:1606038 6480464 Estradiol inhibits the reaction [sodium arsenite results in decreased expression of DNMT3A mRNA], sodium arsenite inhibits the reaction [Estradiol results in decreased expression of DNMT3A mRNA] CTD PMID:22952798 17beta-estradiol increases expression ISO RGD:1606038 6480464 Estradiol results in increased expression of DNMT3A mRNA CTD PMID:30684530 17beta-estradiol multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3A mRNA], [Testosterone co-treated with Estradiol] affects the reaction [estradiol-17 beta-benzoate results in increased expression of DNMT3A mRNA] CTD PMID:22109888 17beta-estradiol decreases expression ISO RGD:1606038 6480464 Estradiol results in decreased expression of DNMT3A mRNA CTD PMID:22952798 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:1620920 6480464 [2 more ... CTD PMID:22343140 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1606038 6480464 2 more ... CTD PMID:31675489 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:1620920 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1620920 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT3A mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNMT3A mRNA CTD PMID:17942748 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DNMT3A mRNA CTD PMID:26455773 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1606038 6480464 resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]], Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter] CTD PMID:22197621 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DNMT3A mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1620920 6480464 Tetrachlorodibenzodioxin results in decreased expression of DNMT3A mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1620920 6480464 Tetrachlorodibenzodioxin results in increased expression of DNMT3A mRNA CTD PMID:15328365 2,4,6-tribromophenol decreases expression ISO RGD:1606038 6480464 2 more ... CTD PMID:31675489 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1620920 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of DNMT3A mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of DNMT3A mRNA CTD PMID:30071829 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression ISO RGD:1620920 6480464 Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA CTD PMID:18098314 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:1620920 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA] CTD PMID:18098314 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1620920 6480464 [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA CTD PMID:29094436 3-methylcholanthrene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT3A protein CTD PMID:21163286 4,4'-diaminodiphenylmethane increases expression ISO RGD:1620920 6480464 4, 4'-diaminodiphenylmethane results in increased expression of DNMT3A mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1620920 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DNMT3A protein CTD PMID:31532523 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1606038 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of DNMT3A gene CTD PMID:31601247 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1620920 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of DNMT3A exon CTD PMID:33297965 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1606038 6480464 DNMT3A protein promotes the reaction [bis(4-hydroxyphenyl)sulfone results in decreased abundance of 5-hydroxymethylcytosine], DNMT3A protein promotes the reaction [bis(4-hydroxyphenyl)sulfone results in decreased expression of TET2 protein] CTD PMID:32105160 4,4'-sulfonyldiphenol increases expression ISO RGD:1606038 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DNMT3A mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of DNMT3A protein CTD PMID:32105160 4-hydroxyphenyl retinamide decreases expression ISO RGD:1620920 6480464 Fenretinide results in decreased expression of DNMT3A mRNA CTD PMID:28973697 4-nonylphenol multiple interactions ISO RGD:1606038 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA more ... CTD PMID:23626723 4-tert-Octylphenol multiple interactions ISO RGD:1606038 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA more ... CTD PMID:23626723 5-(hydroxymethyl)cytosine multiple interactions ISO RGD:1606038 6480464 DNMT3A protein promotes the reaction [bis(4-hydroxyphenyl)sulfone results in decreased abundance of 5-hydroxymethylcytosine], DNMT3A protein promotes the reaction [bisphenol A results in decreased abundance of 5-hydroxymethylcytosine] CTD PMID:32105160 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine inhibits the reaction [Dust results in increased expression of DNMT3A mRNA] CTD PMID:30815999 5-aza-2'-deoxycytidine decreases expression ISO RGD:1606038 6480464 Decitabine results in decreased expression of DNMT3A mRNA, Decitabine results in decreased expression of DNMT3A protein CTD PMID:17991895 more ... 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1620920 6480464 Decitabine inhibits the reaction [Particulate Matter promotes the reaction [[ovalbumin-alum co-treated with Ovalbumin] results in increased expression of DNMT3A protein]], Decitabine inhibits the reaction [Particulate Matter results in increased expression of DNMT3A protein] CTD PMID:30481581 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1606038 6480464 Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of DNMT3A mRNA] more ... CTD PMID:16887905 more ... 5-azacytidine multiple interactions ISO RGD:1606038 6480464 Azacitidine inhibits the reaction [DNMT3A protein binds to MIR497 promoter] CTD PMID:35066776 9-cis-retinoic acid multiple interactions ISO RGD:1606038 6480464 [Arsenicals co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA, [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA CTD PMID:34303791 acetamide increases expression EXP 6480464 acetamide results in increased expression of DNMT3A mRNA CTD PMID:31881176 acetylsalicylic acid multiple interactions ISO RGD:1620920 6480464 Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A mRNA], Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A protein] CTD PMID:34979192 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of DNMT3A mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1620920 6480464 Aflatoxin B1 results in increased expression of DNMT3A mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1606038 6480464 Aflatoxin B1 results in increased methylation of DNMT3A gene, Aflatoxin B1 results in increased methylation of DNMT3A intron CTD PMID:27153756 , PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1606038 6480464 Tretinoin results in decreased expression of DNMT3A mRNA CTD PMID:17273765 , PMID:21934132 allethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA CTD PMID:33051911 , PMID:33396045 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of DNMT3A mRNA CTD PMID:30779732 androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA CTD PMID:25607892 aripiprazole increases expression EXP 6480464 Aripiprazole results in increased expression of DNMT3A mRNA CTD PMID:17868501 arsane affects localization ISO RGD:1620920 6480464 Arsenic affects the localization of DNMT3A protein CTD PMID:22426358 arsane affects response to substance ISO RGD:1606038 6480464 DNMT3A gene SNP affects the susceptibility to Arsenic CTD PMID:27292127 arsane increases expression ISO RGD:1620920 6480464 Arsenic results in increased expression of DNMT3A mRNA CTD PMID:22426358 arsane multiple interactions ISO RGD:1620920 6480464 Arsenic promotes the reaction [DNMT3A protein binds to MYOG promoter] CTD PMID:22426358 arsenic atom multiple interactions ISO RGD:1620920 6480464 Arsenic promotes the reaction [DNMT3A protein binds to MYOG promoter] CTD PMID:22426358 arsenic atom affects response to substance ISO RGD:1606038 6480464 DNMT3A gene SNP affects the susceptibility to Arsenic CTD PMID:27292127 arsenic atom increases expression ISO RGD:1620920 6480464 Arsenic results in increased expression of DNMT3A mRNA CTD PMID:22426358 arsenic atom affects localization ISO RGD:1620920 6480464 Arsenic affects the localization of DNMT3A protein CTD PMID:22426358 arsenite(3-) increases expression ISO RGD:1620920 6480464 arsenite results in increased expression of DNMT3A mRNA CTD PMID:18191166 arsenous acid decreases expression ISO RGD:1606038 6480464 Arsenic Trioxide results in decreased expression of DNMT3A more ... CTD PMID:12667347 more ... arsenous acid multiple interactions ISO RGD:1606038 6480464 S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in decreased expression of DNMT3A protein] CTD PMID:22558281 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of DNMT3A mRNA CTD PMID:29223816 arsenous acid increases expression ISO RGD:1606038 6480464 Arsenic Trioxide results in increased expression of DNMT3A mRNA CTD PMID:25534098 arsenous acid decreases activity ISO RGD:1606038 6480464 Arsenic Trioxide results in decreased activity of DNMT3A protein CTD PMID:20596618 benzene increases expression ISO RGD:1606038 6480464 Benzene results in increased expression of DNMT3A mRNA CTD PMID:21325737 benzo[a]pyrene increases expression ISO RGD:1606038 6480464 Benzo(a)pyrene results in increased expression of DNMT3A mRNA CTD PMID:17879257 benzo[a]pyrene increases expression ISO RGD:1620920 6480464 Benzo(a)pyrene results in increased expression of DNMT3A mRNA, Benzo(a)pyrene results in increased expression of DNMT3A protein CTD PMID:34979192 benzo[a]pyrene multiple interactions ISO RGD:1620920 6480464 Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A mRNA], Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A protein] CTD PMID:34979192 benzo[a]pyrene increases methylation ISO RGD:1606038 6480464 Benzo(a)pyrene results in increased methylation of DNMT3A 3' UTR, Benzo(a)pyrene results in increased methylation of DNMT3A promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1606038 6480464 Benzo(a)pyrene affects the methylation of DNMT3A intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1620920 6480464 Benzo(a)pyrene results in decreased expression of DNMT3A mRNA CTD PMID:20713471 benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:1606038 6480464 7 more ... CTD PMID:20426865 benzo[b]fluoranthene increases expression ISO RGD:1620920 6480464 benzo(b)fluoranthene results in increased expression of DNMT3A mRNA CTD PMID:26377693 bexarotene decreases expression ISO RGD:1620920 6480464 bexarotene results in decreased expression of DNMT3A mRNA CTD PMID:17849452 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1620920 6480464 Mustard Gas results in decreased expression of DNMT3A mRNA CTD PMID:26392148 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1620920 6480464 Diethylhexyl Phthalate results in increased expression of DNMT3A mRNA CTD PMID:20335514 , PMID:25351189 bis(2-ethylhexyl) phthalate affects expression ISO RGD:1620920 6480464 Diethylhexyl Phthalate affects the expression of DNMT3A mRNA CTD PMID:32628958 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1620920 6480464 Diethylhexyl Phthalate results in decreased expression of DNMT3A mRNA CTD PMID:31211961 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1606038 6480464 Diethylhexyl Phthalate results in increased expression of DNMT3A protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of DNMT3A mRNA, Diethylhexyl Phthalate results in increased expression of DNMT3A protein CTD PMID:25280772 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DNMT3A promoter CTD PMID:23359474 bisphenol A increases expression ISO RGD:1620920 6480464 bisphenol A results in increased expression of DNMT3A mRNA, bisphenol A results in increased expression of DNMT3A protein CTD PMID:21980460 more ... bisphenol A decreases expression ISO RGD:1606038 6480464 bisphenol A results in decreased expression of DNMT3A mRNA, bisphenol A results in decreased expression of DNMT3A protein CTD PMID:28597690 , PMID:31675489 bisphenol A multiple interactions ISO RGD:1606038 6480464 [bisphenol A co-treated with decabromobiphenyl ether] results in decreased expression of DNMT3A mRNA more ... CTD PMID:28597690 more ... bisphenol A increases expression ISO RGD:1606038 6480464 bisphenol A results in increased expression of DNMT3A mRNA, bisphenol A results in increased expression of DNMT3A protein CTD PMID:32105160 , PMID:34537452 bisphenol A affects methylation ISO RGD:1620920 6480464 bisphenol A affects the methylation of DNMT3A promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DNMT3A mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DNMT3A promoter more ... CTD PMID:22109888 more ... bisphenol A decreases expression ISO RGD:1620920 6480464 bisphenol A results in decreased expression of DNMT3A mRNA, bisphenol A results in decreased expression of DNMT3A protein CTD PMID:22131059 more ... bisphenol A affects expression ISO RGD:1620920 6480464 bisphenol A affects the expression of DNMT3A mRNA, bisphenol A affects the expression of DNMT3A protein CTD PMID:23418087 , PMID:23716699 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DNMT3A mRNA, bisphenol A results in increased expression of DNMT3A protein CTD PMID:21827818 more ... bisphenol A multiple interactions ISO RGD:1620920 6480464 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA] CTD PMID:22131059 Brodifacoum affects binding ISO RGD:1606038 6480464 bromfenacoum binds to DNMT3A protein CTD PMID:31595789 buta-1,3-diene decreases expression ISO RGD:1620920 6480464 1, 3-butadiene results in decreased expression of DNMT3A mRNA CTD PMID:25237060 , PMID:30552462 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of DNMT3A mRNA CTD PMID:26888303 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA CTD PMID:25607892 cadmium dichloride multiple interactions ISO RGD:1606038 6480464 [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in decreased expression of ERCC1 mRNA more ... CTD PMID:22112500 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of DNMT3A mRNA CTD PMID:33865896 cadmium dichloride increases expression ISO RGD:1606038 6480464 Cadmium Chloride results in increased expression of DNMT3A mRNA, Cadmium Chloride results in increased expression of DNMT3A protein CTD PMID:22112500 more ... cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of DNMT3A mRNA, Cadmium Chloride affects the expression of DNMT3A protein CTD PMID:22957049 more ... caffeine increases expression EXP 6480464 Caffeine results in increased expression of DNMT3A mRNA CTD PMID:24717552 caffeine increases phosphorylation ISO RGD:1606038 6480464 Caffeine results in increased phosphorylation of DNMT3A protein CTD PMID:35688186 cannabidiol decreases methylation ISO RGD:1620920 6480464 Cannabidiol results in decreased methylation of DNMT3A gene CTD PMID:32579259 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of DNMT3A mRNA CTD PMID:23125180 chlorpyrifos increases methylation EXP 6480464 Chlorpyrifos results in increased methylation of DNMT3A gene CTD PMID:32905263 choline multiple interactions ISO RGD:1620920 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A mRNA more ... CTD PMID:20548288 more ... citalopram affects expression EXP 6480464 Citalopram affects the expression of DNMT3A mRNA CTD PMID:21682946 clofibrate increases expression ISO RGD:1620920 6480464 Clofibrate results in increased expression of DNMT3A mRNA CTD PMID:17585979 copper atom decreases expression ISO RGD:1606038 6480464 Copper results in decreased expression of DNMT3A mRNA CTD PMID:34871762 copper(0) decreases expression ISO RGD:1606038 6480464 Copper results in decreased expression of DNMT3A mRNA CTD PMID:34871762 copper(II) sulfate decreases expression ISO RGD:1606038 6480464 Copper Sulfate results in decreased expression of DNMT3A mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of DNMT3A mRNA CTD PMID:30423288 coumarin decreases phosphorylation ISO RGD:1606038 6480464 coumarin results in decreased phosphorylation of DNMT3A protein CTD PMID:35688186 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of DNMT3A mRNA CTD PMID:26577399 curcumin decreases expression ISO RGD:1606038 6480464 Curcumin results in decreased expression of DNMT3A mRNA CTD PMID:23593078 curcumin decreases expression ISO RGD:1620920 6480464 Curcumin analog results in decreased expression of DNMT3A protein CTD PMID:26991801 , PMID:29228771 cycloheximide multiple interactions EXP 6480464 [Cycloheximide co-treated with FASLG protein] results in decreased expression of DNMT3A mRNA, [Cycloheximide co-treated with FASLG protein] results in decreased expression of DNMT3A protein CTD PMID:19833194 cyclosporin A decreases methylation ISO RGD:1606038 6480464 Cyclosporine results in decreased methylation of DNMT3A promoter CTD PMID:27989131 cyhalothrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of DNMT3A mRNA CTD PMID:35605701 D-penicillamine decreases expression ISO RGD:1620920 6480464 Penicillamine results in decreased expression of DNMT3A mRNA CTD PMID:22945834 daidzein multiple interactions EXP 6480464 [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA CTD PMID:28964809 daidzein 7-O-beta-D-glucoside multiple interactions EXP 6480464 [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA CTD PMID:28964809 DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of DNMT3A mRNA CTD PMID:30153481 DDT decreases expression EXP 6480464 DDT results in decreased expression of DNMT3A mRNA CTD PMID:19797855 decabromodiphenyl ether decreases expression ISO RGD:1606038 6480464 decabromobiphenyl ether results in decreased expression of DNMT3A mRNA CTD PMID:28597690 decabromodiphenyl ether multiple interactions ISO RGD:1606038 6480464 [bisphenol A co-treated with decabromobiphenyl ether] results in decreased expression of DNMT3A mRNA CTD PMID:28597690 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of DNMT3A mRNA, deoxynivalenol results in increased expression of DNMT3A protein CTD PMID:32738333 desferrioxamine B decreases expression ISO RGD:1606038 6480464 Deferoxamine results in decreased expression of DNMT3A mRNA CTD PMID:23483119 desferrioxamine B increases expression ISO RGD:1606038 6480464 Deferoxamine results in increased expression of DNMT3A mRNA CTD PMID:23483119 dexamethasone multiple interactions ISO RGD:1620920 6480464 [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA CTD PMID:29094436 diarsenic trioxide multiple interactions ISO RGD:1606038 6480464 S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in decreased expression of DNMT3A protein] CTD PMID:22558281 diarsenic trioxide increases expression ISO RGD:1606038 6480464 Arsenic Trioxide results in increased expression of DNMT3A mRNA CTD PMID:25534098 diarsenic trioxide decreases activity ISO RGD:1606038 6480464 Arsenic Trioxide results in decreased activity of DNMT3A protein CTD PMID:20596618 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of DNMT3A mRNA CTD PMID:29223816 diarsenic trioxide decreases expression ISO RGD:1606038 6480464 Arsenic Trioxide results in decreased expression of DNMT3A more ... CTD PMID:12667347 more ... dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DNMT3A promoter CTD PMID:23359474 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of DNMT3A protein CTD PMID:26745512 diethylstilbestrol increases expression ISO RGD:1620920 6480464 Diethylstilbestrol results in increased expression of DNMT3A mRNA CTD PMID:16714842 , PMID:24316720 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of DNMT3A mRNA CTD PMID:35605701 Difenacoum affects binding ISO RGD:1606038 6480464 difenacoum binds to DNMT3A protein CTD PMID:31595789 disodium selenite decreases expression ISO RGD:1606038 6480464 Sodium Selenite results in decreased expression of DNMT3A mRNA CTD PMID:18676679 doxorubicin affects expression ISO RGD:1606038 6480464 Doxorubicin affects the expression of DNMT3A mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:1606038 6480464 Endosulfan results in increased expression of DNMT3A mRNA, Endosulfan results in increased expression of DNMT3A protein CTD PMID:29054638 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA CTD PMID:25607892 ethanol multiple interactions ISO RGD:1620920 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of DNMT3A protein] CTD PMID:23395981 ethanol affects expression ISO RGD:1606038 6480464 Ethanol affects the expression of DNMT3A protein CTD PMID:35149083 ethanol affects splicing ISO RGD:1620920 6480464 Ethanol affects the splicing of DNMT3A mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1620920 6480464 Ethanol affects the expression of DNMT3A mRNA CTD PMID:26730594 ethanol decreases expression ISO RGD:1620920 6480464 Ethanol results in decreased expression of DNMT3A protein CTD PMID:23395981 ethanol increases expression ISO RGD:1620920 6480464 Ethanol results in increased expression of DNMT3A mRNA CTD PMID:23395981 ethanol increases degradation ISO RGD:1620920 6480464 Ethanol results in increased degradation of DNMT3A protein CTD PMID:23395981 fenvalerate multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA CTD PMID:33051911 , PMID:33396045 Flocoumafen affects binding ISO RGD:1606038 6480464 flocoumafen binds to DNMT3A protein CTD PMID:31595789 folic acid affects expression ISO RGD:1606038 6480464 Folic Acid affects the expression of DNMT3A mRNA CTD PMID:17311948 folic acid increases expression ISO RGD:1620920 6480464 Folic Acid results in increased expression of DNMT3A mRNA, Folic Acid results in increased expression of DNMT3A protein CTD PMID:30920123 folic acid affects expression ISO RGD:1620920 6480464 Folic Acid affects the expression of DNMT3A mRNA CTD PMID:29986310 folic acid multiple interactions ISO RGD:1620920 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A mRNA more ... CTD PMID:20548288 more ... formaldehyde decreases expression ISO RGD:1606038 6480464 Formaldehyde results in decreased expression of DNMT3A mRNA, Formaldehyde results in decreased expression of DNMT3A protein CTD PMID:21745553 fulvestrant multiple interactions ISO RGD:1620920 6480464 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA] CTD PMID:22131059 fulvestrant multiple interactions ISO RGD:1606038 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DNMT3A gene, Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3A protein] CTD PMID:31601247 , PMID:34537452 fumonisin B1 decreases activity ISO RGD:1606038 6480464 fumonisin B1 results in decreased activity of DNMT3A protein CTD PMID:24280379 genistein decreases expression ISO RGD:1606038 6480464 Genistein results in decreased expression of DNMT3A mRNA CTD PMID:23593078 genistein multiple interactions EXP 6480464 [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA CTD PMID:28964809 genistein 7-O-beta-D-glucoside multiple interactions EXP 6480464 [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA CTD PMID:28964809 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of DNMT3A mRNA CTD PMID:33387578 gibberellin A3 decreases expression EXP 6480464 gibberellic acid results in decreased expression of DNMT3A mRNA CTD PMID:31733319 glycitein multiple interactions EXP 6480464 [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA CTD PMID:28964809 glycitin multiple interactions EXP 6480464 [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA CTD PMID:28964809 glyphosate increases expression ISO RGD:1606038 6480464 glyphosate results in increased expression of DNMT3A mRNA CTD PMID:33803994 glyphosate increases methylation EXP 6480464 glyphosate results in increased methylation of DNMT3A gene CTD PMID:31011160 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of DNMT3A mRNA CTD PMID:26302742 , PMID:33512083 guggulsterone decreases expression ISO RGD:1606038 6480464 pregna-4 more ... CTD PMID:23593078 hexane decreases methylation EXP 6480464 n-hexane results in decreased methylation of DNMT3A promoter CTD PMID:23740543 hydrogen peroxide increases expression ISO RGD:1606038 6480464 Hydrogen Peroxide results in increased expression of DNMT3A mRNA CTD PMID:27655674 hydroquinone decreases expression ISO RGD:1606038 6480464 hydroquinone results in decreased expression of DNMT3A mRNA, hydroquinone results in decreased expression of DNMT3A protein CTD PMID:22245671 , PMID:27979589 hydroquinone affects expression ISO RGD:1606038 6480464 hydroquinone affects the expression of DNMT3A mRNA CTD PMID:34612549 hydroquinone increases expression ISO RGD:1606038 6480464 hydroquinone results in increased expression of DNMT3A mRNA CTD PMID:31899212 ibuprofen decreases expression ISO RGD:1606038 6480464 Ibuprofen results in decreased expression of DNMT3A mRNA CTD PMID:29665328 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of DNMT3A protein CTD PMID:24945829 isoprenaline decreases expression ISO RGD:1620920 6480464 Isoproterenol results in decreased expression of DNMT3A mRNA CTD PMID:20003209 L-methionine multiple interactions ISO RGD:1620920 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A mRNA more ... CTD PMID:20548288 more ... L-methionine multiple interactions ISO RGD:1606038 6480464 [Methionine co-treated with 6-formylindolo(3, 2-b)carbazole] results in increased expression of DNMT3A mRNA CTD PMID:31626383 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of DNMT3A protein CTD PMID:23246732 lead diacetate multiple interactions ISO RGD:1620920 6480464 [lead acetate results in increased abundance of Lead] which affects the expression of DNMT3A protein CTD PMID:29481626 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of DNMT3A protein CTD PMID:23246732 lead nitrate multiple interactions ISO RGD:1606038 6480464 4-((3-bromophenyl)amino)-6 more ... CTD PMID:24639330 lead nitrate decreases expression ISO RGD:1606038 6480464 lead nitrate results in decreased expression of DNMT3A mRNA, lead nitrate results in decreased expression of DNMT3A protein CTD PMID:24639330 lead(0) decreases expression ISO RGD:1606038 6480464 Lead results in decreased expression of DNMT3A mRNA, Lead results in decreased expression of DNMT3A protein CTD PMID:22272629 lead(0) multiple interactions ISO RGD:1620920 6480464 [lead acetate results in increased abundance of Lead] which affects the expression of DNMT3A protein CTD PMID:29481626 lead(2+) decreases expression ISO RGD:1606038 6480464 Lead results in decreased expression of DNMT3A mRNA, Lead results in decreased expression of DNMT3A protein CTD PMID:22272629 lead(2+) multiple interactions ISO RGD:1620920 6480464 [lead acetate results in increased abundance of Lead] which affects the expression of DNMT3A protein CTD PMID:29481626 methotrexate increases expression ISO RGD:1606038 6480464 Methotrexate results in increased expression of DNMT3A mRNA CTD PMID:24449571 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of DNMT3A mRNA CTD PMID:23303685 methylmercury chloride increases expression ISO RGD:1606038 6480464 methylmercuric chloride results in increased expression of DNMT3A protein CTD PMID:33454822 microcystin-LR increases expression ISO RGD:1606038 6480464 cyanoginosin LR results in increased expression of DNMT3A mRNA CTD PMID:29518473 mitomycin C decreases expression ISO RGD:1620920 6480464 Mitomycin results in decreased expression of DNMT3A protein CTD PMID:27032448 Monobutylphthalate decreases expression ISO RGD:1620920 6480464 monobutyl phthalate results in decreased expression of DNMT3A protein CTD PMID:26745512 morphine affects expression ISO RGD:1620920 6480464 Morphine affects the expression of DNMT3A mRNA CTD PMID:33891991 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1620920 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of DNMT3A protein] CTD PMID:23395981 N-methyl-4-phenylpyridinium increases expression ISO RGD:1620920 6480464 1-Methyl-4-phenylpyridinium results in increased expression of DNMT3A protein CTD PMID:26558463 N-methylformamide affects expression ISO RGD:1620920 6480464 methylformamide affects the expression of DNMT3A mRNA, methylformamide analog affects the expression of DNMT3A mRNA CTD PMID:17040096 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT3A protein CTD PMID:21163286 ozone decreases expression EXP 6480464 Ozone results in decreased expression of DNMT3A mRNA CTD PMID:29947284 p-tert-Amylphenol multiple interactions ISO RGD:1606038 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA more ... CTD PMID:23626723 paracetamol affects expression ISO RGD:1620920 6480464 Acetaminophen affects the expression of DNMT3A mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DNMT3A mRNA CTD PMID:29665328 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA CTD PMID:25607892 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DNMT3A mRNA CTD PMID:25607892 paraquat decreases expression ISO RGD:1606038 6480464 Paraquat results in decreased expression of DNMT3A mRNA, Paraquat results in decreased expression of DNMT3A protein CTD PMID:31189234 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of DNMT3A protein CTD PMID:20621739 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1606038 6480464 perfluorooctane sulfonic acid results in decreased expression of DNMT3A mRNA, perfluorooctane sulfonic acid results in decreased expression of DNMT3A protein CTD PMID:31508952 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1620920 6480464 perfluorooctane sulfonic acid results in decreased expression of DNMT3A protein CTD PMID:26178269 perfluorooctanoic acid increases expression ISO RGD:1606038 6480464 perfluorooctanoic acid results in increased expression of DNMT3A mRNA CTD PMID:22425687 perfluorooctanoic acid decreases expression ISO RGD:1620920 6480464 perfluorooctanoic acid results in decreased expression of DNMT3A mRNA CTD PMID:32320774 perfluorooctanoic acid multiple interactions ISO RGD:1620920 6480464 [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA CTD PMID:29094436 perfluorooctanoic acid decreases expression ISO RGD:1606038 6480464 perfluorooctanoic acid results in decreased expression of DNMT3A protein CTD PMID:26879310 phenobarbital affects expression ISO RGD:1620920 6480464 Phenobarbital affects the expression of DNMT3A mRNA CTD PMID:19482888 , PMID:23091169 pirinixic acid multiple interactions ISO RGD:1620920 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DNMT3A mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1620920 6480464 pirinixic acid results in decreased expression of DNMT3A mRNA CTD PMID:18445702 poly(I:C) multiple interactions ISO RGD:1606038 6480464 [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA, [Arsenicals co-treated with Poly I-C] results in increased expression of DNMT3A mRNA CTD PMID:34303791 procyanidin B2 increases expression ISO RGD:1606038 6480464 procyanidin B2 results in increased expression of DNMT3A mRNA CTD PMID:25839702 pterostilbene multiple interactions ISO RGD:1606038 6480464 [resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA CTD PMID:26459286 quartz decreases expression ISO RGD:1606038 6480464 Quartz results in decreased expression of DNMT3A mRNA CTD PMID:27917503 quinoline decreases activity ISO RGD:1620920 6480464 quinoline analog results in decreased activity of DNMT3A protein CTD PMID:19417133 resveratrol decreases expression ISO RGD:1606038 6480464 resveratrol results in decreased expression of DNMT3A mRNA CTD PMID:23593078 resveratrol multiple interactions ISO RGD:1606038 6480464 [resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA, resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]] CTD PMID:22197621 , PMID:26459286 S-adenosyl-L-methioninate multiple interactions ISO RGD:1620920 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA] CTD PMID:18098314 S-adenosyl-L-methioninate multiple interactions ISO RGD:1606038 6480464 S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT3A protein] CTD PMID:22558281 S-adenosyl-L-methionine multiple interactions ISO RGD:1620920 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA] CTD PMID:18098314 S-adenosyl-L-methionine multiple interactions ISO RGD:1606038 6480464 S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT3A protein] CTD PMID:22558281 Salinomycin decreases expression ISO RGD:1606038 6480464 salinomycin results in decreased expression of DNMT3A mRNA CTD PMID:19682730 sinefungin decreases activity ISO RGD:1620920 6480464 sinefungin results in decreased activity of DNMT3A protein CTD PMID:23671287 sodium arsenite increases expression ISO RGD:1620920 6480464 sodium arsenite results in increased expression of DNMT3A mRNA CTD PMID:19822182 sodium arsenite increases expression ISO RGD:1606038 6480464 sodium arsenite results in increased expression of DNMT3A mRNA, sodium arsenite results in increased expression of DNMT3A protein CTD PMID:26409248 , PMID:30191986 sodium arsenite multiple interactions ISO RGD:1620920 6480464 [sodium arsenite co-treated with Folic Acid] results in decreased expression of DNMT3A mRNA CTD PMID:22959928 sodium arsenite decreases expression ISO RGD:1606038 6480464 sodium arsenite results in decreased expression of DNMT3A mRNA, sodium arsenite results in decreased expression of DNMT3A protein CTD PMID:17107663 more ... sodium arsenite multiple interactions ISO RGD:1606038 6480464 Decitabine inhibits the reaction [sodium arsenite results in increased expression of DNMT3A protein] more ... CTD PMID:22952798 , PMID:26409248 streptozocin multiple interactions ISO RGD:1620920 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of DNMT3A mRNA, [Streptozocin co-treated with Dietary Fats] results in increased expression of DNMT3A protein CTD PMID:29127188 sulforaphane increases expression ISO RGD:1606038 6480464 sulforaphane results in increased expression of DNMT3A mRNA CTD PMID:30684530 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of DNMT3A mRNA, T-2 Toxin results in increased expression of DNMT3A protein CTD PMID:31279042 tamoxifen decreases expression ISO RGD:1620920 6480464 Tamoxifen results in decreased expression of DNMT3A mRNA CTD PMID:25123088 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3A mRNA] more ... CTD PMID:20056826 , PMID:22109888 tetrachloromethane multiple interactions ISO RGD:1620920 6480464 DNMT3A protein affects the reaction [Carbon Tetrachloride results in decreased expression of SEPTIN9 protein] CTD PMID:27939986 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of DNMT3A protein CTD PMID:35544339 thimerosal decreases expression ISO RGD:1606038 6480464 Thimerosal results in decreased expression of DNMT3A mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DNMT3A mRNA CTD PMID:34492290 trichloroethene decreases expression ISO RGD:1620920 6480464 Trichloroethylene results in decreased expression of DNMT3A mRNA CTD PMID:22407948 more ... trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of DNMT3A gene CTD PMID:27618143 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DNMT3A mRNA CTD PMID:27618143 trimellitic anhydride increases expression ISO RGD:1620920 6480464 trimellitic anhydride results in increased expression of DNMT3A mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1620920 6480464 troglitazone results in decreased expression of DNMT3A mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:1620920 6480464 Tungsten results in decreased expression of DNMT3A mRNA CTD PMID:30912803 tyrphostin AG 1478 multiple interactions ISO RGD:1606038 6480464 RTKI cpd inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA] CTD PMID:24639330 uranium atom increases expression EXP 6480464 Uranium results in increased expression of DNMT3A mRNA CTD PMID:29024790 urethane decreases expression ISO RGD:1606038 6480464 Urethane results in decreased expression of DNMT3A mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1606038 6480464 Valproic Acid affects the expression of DNMT3A mRNA CTD PMID:25979313 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of DNMT3A mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1606038 6480464 Valproic Acid results in increased expression of DNMT3A mRNA CTD PMID:28001369 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of DNMT3A mRNA CTD PMID:25423262 vinclozolin multiple interactions EXP 6480464 [Testosterone co-treated with vinclozolin] results in increased expression of DNMT3A mRNA CTD PMID:20056826 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of DNMT3A mRNA CTD PMID:20056826 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of DNMT3A mRNA CTD PMID:18042343 vinyl carbamate increases expression ISO RGD:1620920 6480464 vinyl carbamate results in increased expression of DNMT3A mRNA CTD PMID:17849452 vitamin E decreases expression ISO RGD:1606038 6480464 Vitamin E results in decreased expression of DNMT3A mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1606038 6480464 vorinostat results in decreased expression of DNMT3A mRNA CTD PMID:27188386 withaferin A decreases expression ISO RGD:1606038 6480464 withaferin A results in decreased expression of DNMT3A mRNA CTD PMID:23593078 wortmannin multiple interactions ISO RGD:1606038 6480464 wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein] CTD PMID:23626723 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of DNMT3A mRNA, Zinc deficiency results in increased expression of DNMT3A protein CTD PMID:19111725 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of DNMT3A mRNA] CTD PMID:19111725 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of DNMT3A mRNA, Zinc deficiency results in increased expression of DNMT3A protein CTD PMID:19111725 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of DNMT3A mRNA] CTD PMID:19111725